About Acute Hepatic Porphyria

Overview

Acute hepatic porphyria (AHP) is a group of rare genetic disorders that can be very serious. There are four types:

  • Acute intermittent porphyria (AIP)
  • Variegate porphyria (VP)
  • Hereditary coproporphyria (HCP)
  • Delta-aminolevulinic acid (ALA) dehydratase-deficiency porphyria

These happen because of problems with certain enzymes that help make heme, a key part of red blood cells. When these enzymes don’t work properly, certain chemicals called porphyrin precursors—like ALA and porphobilinogen (PBG)—that are normally broken down in the body build up instead. This buildup causes many of the symptoms of AHP.

The worst symptoms occur during sudden attacks, which can include severe stomach pain, nausea, vomiting, confusion, muscle weakness, and dark-colored urine. AHP can also cause long-term problems that affect daily life.

Causes and Risk Factors

Acute hepatic porphyria (AHP) happens because some enzymes that help produce heme, a key part of red blood cells, don’t work properly. It’s also an inherited disorder, meaning it’s passed from parents to their children through genes.

Non-modifiable risk factors for AHP, which are factors that cannot be changed or controlled to lower chances of getting the disease, include:

  • Genetics: AHP a is an inherited disorder, so having a family history of the condition increases the risk of developing it.

Modifiable risk factors for AHP, which are lifestyle and environmental factors that can be changed to lower chances of getting the disease, include:

  • Environmental triggers: Certain environmental factors can trigger acute attacks in individuals with AHP. These triggers can include hormonal changes (such as those during menstruation or pregnancy), exposure to certain medications or drugs, alcohol consumption, and exposure to certain chemicals or toxins.
  • Lifestyle choices: Certain lifestyle choices can also affect the severity and frequency of acute attacks. For example, stress, poor nutrition, and excessive alcohol consumption can increase the risk of experiencing an attack.

It is important for individuals with acute hepatic porphyria to be aware of these risk factors and take steps to manage them in order to reduce the frequency and severity of acute attacks. This may involve avoiding known triggers, making healthy lifestyle choices, and working closely with healthcare professionals to develop a personalized management plan.

Symptoms

The most common symptoms of AHP can range from early signs to more severe complications:

  • Severe, diffuse abdominal pain: AHP often causes intense, widespread pain in the abdomen due to nerve involvement during an attack.
  • Nausea: A common result of AHP attacks, often linked to abdominal pain and digestive system disruption
  • Weakness: AHP can affect the muscles, leading to significant loss of strength during attacks.
  • Changes in urine color: A telltale sign of AHP, caused by the buildup of certain substances in the body that darken the urine

Later stage or more severe symptoms may include:

  • Tachycardia: A rapid heart rate, often over 100 beats per minute
  • Hyponatremia: AHP can disrupt salt balance in the body, leading to low sodium levels and associated confusion or fatigue.
  • Mental status changes: Confusion, disorientation, or memory issues
  • Hypertension: High blood pressure often results from the stress AHP puts on the body during an attack.
  • Seizures: AHP can affect the nervous system, leading to seizures.
  • Delirium: Severe confusion and inability to think clearly
  • Paralysis: In severe cases of AHP, nerve damage can lead to temporary or permanent muscle paralysis.
  • Posterior Reversible Encephalopathy Syndrome (PRES): A rare but serious brain disorder triggered by severe AHP attacks, leading to headaches, seizures, and vision changes

In severe cases, permanent nerve damage or death can occur if treatment is delayed, or individuals are continuously exposed to triggers. If you experience any of these symptoms, it’s important to seek medical advice immediately. Early diagnosis and treatment can prevent complications and reduce the risk of permanent damage or life-threatening outcomes.

Diagnosis

To diagnose AHP, healthcare providers commonly perform a series of examinations, tests, and procedures. These include:

  • Physical Exam: During the physical exam, the healthcare provider will look for any physical signs of a medical problem, such as pain, swelling, or the presence of masses within the body.
  • Clinical History: Gathering a detailed medical history from the patient can provide important insights into their symptoms and help identify patterns that are characteristic of AHP.
  • Lab Tests: Specific lab tests are often recommended to help diagnose AHP. These may include a blood draw to check for abnormal levels of certain substances in the blood that are associated with porphyria. Additionally, urine tests can be performed to measure levels of porphobilinogen (PBG). High levels of PBG can indicate an AHP attack.
  • Imaging Studies: Imaging studies like X-rays or MRI scans may be used to examine the internal structures of the body and identify any abnormalities that could be related to AHP.
  • Genetic Testing: Genetic testing can be performed to find mutations in the HMBS gene, which is associated with this condition. This type of testing can confirm or rule out a suspected genetic disease and provide valuable information for both diagnosis and family planning.

In addition to these common diagnostic procedures, there are additional examinations, tests, and procedures that can be used to determine the stage or severity of acute hepatic porphyria. These may include:

  • Follow-Up Exams: If any symptoms worsen or change after the initial physical exam, it is important to follow up with the healthcare provider for further evaluation and monitoring.
  • Additional Lab Tests: Depending on the specific needs of each patient, additional lab tests may be ordered to evaluate liver function and assess any complications related to AHP.

It's important to note that diagnosing AHP can sometimes be tricky because its symptoms come and go and may not clearly point to the condition. Therefore, doctors rely on a combination of clinical exams, lab tests, imaging studies, and genetic testing to make an accurate diagnosis and determine the stage or severity of AHP.

Treatment Options

The goals of treatment for acute hepatic porphyria (AHP) are to manage symptoms, prevent complications, and reduce the production of heme in the liver. There is currently no cure for AHP, so treatment focuses on symptom management and improving quality of life.

Here are some of the treatment options that may be recommended for individuals with AHP:

  • Medications:
    • Parenteral opiates: These are strong pain relievers used to help manage severe abdominal pain associated with AHP.
      • Because of the potential for dependence and addiction, opioids are usually prescribed for short-term use only, not as a long-term solution. It’s important to discuss safer medication options for managing chronic pain with your doctor.
    • Anti-emetics: These medications help relieve nausea, a common symptom during AHP attacks.
    • Beta-blockers and calcium channel blockers: These are prescribed to manage tachycardia (rapid heart rate) and hypertension (high blood pressure) that can occur during attacks.
    • Seizure medications: Drugs like diazepam or clonazepam can help control seizures that may arise in severe cases of AHP.
    • Intravenous heme therapy: In severe acute attacks, this therapy may be used to regulate the ALAS1 protein, which plays a role in heme production, and improve symptoms.
    • Beta carotene and afamelanotide: These treatments help increase sunlight tolerance in people with AHP. Beta carotene boosts sun tolerance, while afamelanotide increases skin pigmentation by enhancing melanin production, providing further protection.
  • Therapeutic Procedures:
    • IV heme therapy: This involves receiving IV infusions of hematin over four days. It helps regulate heme production in the liver, which can relieve symptoms of AHP.
    • Gene therapies: These aim to increase the activity of the enzyme that is lacking in AHP, helping to restore proper heme production. However, more research is needed before these treatments can be widely used.
  • Lifestyle changes:
    • Avoid triggers: It's important to steer clear of things that can worsen symptoms, such as:
      • Certain medications
      • Excessive alcohol consumption
      • Smoking
      • Severe calorie restriction
    • Maintain a balanced diet: Eating regularly and including a variety of foods is crucial for overall health and can help reduce attacks.
    • Treat infections right away: Taking care of any infections right away can prevent complications related to AHP.
    • Reduce stress levels: Stress can trigger attacks, so finding ways to relax, like through exercise or meditation, can be beneficial.
    • Sunlight avoidance: Since sunlight can trigger skin symptoms in some individuals with AHP. Avoiding direct sunlight or using protective clothing and sunscreen can help prevent problems.

Each of these treatment options plays a role in managing the symptoms of AHP and improving the quality of life for those affected by the condition. Remember that every individual with AHP may have different treatment needs based on their specific symptoms and medical history. It's important to work closely with a healthcare team that includes specialists like pediatricians, neurologists, hematologists, and psychiatrists to develop a personalized treatment plan.

Please note that while these treatments can help manage symptoms and improve quality of life for individuals with AHP, there is currently no cure for the condition. Treatment focuses on symptom management and preventing complications from occurring or worsening over time.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.